These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1180 related articles for article (PubMed ID: 15960923)
1. Mutation and homozygous deletion analyses of genes that control the G1/S transition of the cell cycle in skin melanoma: p53, p21, p16 and p15. Soto Martínez JL; Cabrera Morales CM; Serrano Ortega S; López-Nevot MA Clin Transl Oncol; 2005 May; 7(4):156-64. PubMed ID: 15960923 [TBL] [Abstract][Full Text] [Related]
2. Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B. Soto JL; Cabrera CM; Serrano S; López-Nevot MA BMC Cancer; 2005 Apr; 5():36. PubMed ID: 15819981 [TBL] [Abstract][Full Text] [Related]
3. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas. Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005 [TBL] [Abstract][Full Text] [Related]
4. A single nucleotide polymorphism in the 3'untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare. Kumar R; Smeds J; Berggren P; Straume O; Rozell BL; Akslen LA; Hemminki K Int J Cancer; 2001 Nov; 95(6):388-93. PubMed ID: 11668523 [TBL] [Abstract][Full Text] [Related]
5. Mutations of p16 and p15 tumor suppressor genes and replication errors contribute independently to the pathogenesis of sporadic malignant melanoma. Matsumura Y; Nishigori C; Yagi T; Imamura S; Takebe H Arch Dermatol Res; 1998 Apr; 290(4):175-80. PubMed ID: 9617435 [TBL] [Abstract][Full Text] [Related]
6. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia. Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127 [TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors. Heidenreich A; Gaddipati JP; Moul JW; Srivastava S J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401 [TBL] [Abstract][Full Text] [Related]
8. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Drexler HG Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410 [TBL] [Abstract][Full Text] [Related]
9. A comparative study of glioma cell lines for p16, p15, p53 and p21 gene alterations. Zhang S; Endo S; Koga H; Ichikawa T; Feng X; Onda K; Washiyama K; Kumanishi T Jpn J Cancer Res; 1996 Sep; 87(9):900-7. PubMed ID: 8878451 [TBL] [Abstract][Full Text] [Related]
10. Homozygous deletions of p16/MTS1 and p15/MTS2 genes are frequent in t(1;19)-negative but not in t(1;19)-positive B precursor acute lymphoblastic leukemia in childhood. Ohnishi H; Hanada R; Horibe K; Hongo T; Kawamura M; Naritaka S; Bessho F; Yanagisawa M; Nobori T; Yamamori S; Hayashi Y Leukemia; 1996 Jul; 10(7):1104-10. PubMed ID: 8683987 [TBL] [Abstract][Full Text] [Related]
11. Deletions and point mutations of p16,p15 gene in primary tumors and tumor cell lines. Yonghao T; Qian H; Chuanyuan L; Yandell DW Chin Med Sci J; 1999 Dec; 14(4):200-5. PubMed ID: 12894891 [TBL] [Abstract][Full Text] [Related]
12. Cell cycle regulators in bladder cancer: relationship to schistosomiasis. Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562 [TBL] [Abstract][Full Text] [Related]
13. Homozygous deletions but no sequence mutations in coding regions of p15 or p16 in human primary bladder tumors. Packenham JP; Taylor JA; Anna CH; White CM; Devereux TR Mol Carcinog; 1995 Nov; 14(3):147-51. PubMed ID: 7576106 [TBL] [Abstract][Full Text] [Related]
14. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers. Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033 [TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Edmunds SC; Kelsell DP; Hungerford JL; Cree IA Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501 [TBL] [Abstract][Full Text] [Related]
16. Alterations of p16INK4A and p15INK4B genes in gastric carcinomas. Lee YY; Kang SH; Seo JY; Jung CW; Lee KU; Choe KJ; Kim BK; Kim NK; Koeffler HP; Bang YJ Cancer; 1997 Nov; 80(10):1889-96. PubMed ID: 9366289 [TBL] [Abstract][Full Text] [Related]
17. Lack of evidence for mutations or deletions in the CDKN2A/p16 and CDKN2B/p15 genes of Brazilian neuroblastoma patients. Bassi CL; Martelli L; Cipolotti R; Scrideli CA; Defávery R; Tone LG Braz J Med Biol Res; 2004 Nov; 37(11):1683-7. PubMed ID: 15517085 [TBL] [Abstract][Full Text] [Related]
18. Frequent abnormalities of the p15 and p16 genes in mycosis fungoides and sezary syndrome. Scarisbrick JJ; Woolford AJ; Calonje E; Photiou A; Ferreira S; Orchard G; Russell-Jones R; Whittaker SJ J Invest Dermatol; 2002 Mar; 118(3):493-9. PubMed ID: 11874489 [TBL] [Abstract][Full Text] [Related]
19. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas. Tahara H; Smith AP; Gaz RD; Arnold A J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of mutant p53 and c-erbB-2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: with respect to histological subtypes and stages. Wu MS; Shun CT; Sheu JC; Wang HP; Wang JT; Lee WJ; Chen CJ; Wang TH; Lin JT J Gastroenterol Hepatol; 1998 Mar; 13(3):305-10. PubMed ID: 9570245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]